Philip Morris
Tobacco Smoke Inhalation Pattern, Tobacco Type, and Bladder Cancer in Spain
Fields
- Author
- Errezola, M.
- Escolar, A.
- Gonzalez, C.A.
- Izarzugaza, I.
- Lopezabente, G.
- Nebot, M.
- Riboli, E.
- Escolar, A.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- CARCHMAN,RICHARD/OFFICE
- Litigation
- Iwoh/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R530
- Named Organization
- Jerez Hospital
- La Esperanza Hospital
- La Linea Hospital
- Mataro Hospital
- Mutua Terrassa Hospital
- Nuestra Senora De Aranzazu Hospital
- Oncological Inst of Guipuzcoa
- Ramon + Gajal Hospital
- Servicio De Epidemiologia Del Cancer
- Basque Government
- Basque Inst of Statistics
- Bilbao Civil Hospital
- Cadiz Hospital
- Centro Nacional De Epidemiologia
- Cruces Hospital
- Dept of Health + Consumer Affairs
- Fondo De Investigacion Sanitaria
- Guipuzcoa Hospital
- Hospital Del Mar
- Intl Agency for Research on Cancer
- La Esperanza Hospital
- Author (Organization)
- American Journal of Epidemiology
- Andalucian Health Service
- Barcelona Town Hall
- Basque Government
- Carlos III Inst of Health
- Dept of Health + Social Security
- Hospital Sant Jaume I Santa Magdalena
- Intl Agency for Research on Cancer
- Johns Hopkins Univ
- Municipal Health Inst
- Natl Center for Epidemiology
- Andalucian Health Service
- Named Person
- Abraira, V.
- Agudo, A.
- Arocena, F.
- Aurteneche, J.
- Badia, A.
- Berrino, F.
- Camacho, J.
- Castella, J.
- Cirera, L.
- Diez, M.
- Elexpe, X.
- Escudero, A.
- Fabregat, J.
- Flores, J.
- Gay, M.
- Gelabert, A.
- Guzman, A.
- Hernaez, I.
- Kilbourne, E.
- Lahoz, E.
- Larburu, R.
- Lopezabente, G.
- Marco, V.
- Mateos, J.
- Matz, J.
- Paluzie, G.
- Perez, A.
- Planas, J.
- Posada, M.
- Pozo, F.
- Roldan, R.
- Ruiz, A.
- Saracci, R.
- Telleria, R.
- Terracini, B.
- Villarino, I.
- Agudo, A.
- Master ID
- 2063629314/9764
Related Documents:- 2063629314-9764 Book 50 Tab Number 1 - 60 Low Tar and Disease
- 2063629320-9324 Tar Yields of Cigarettes and the Risk of Oesophageal Cancer
- 2063629326-9331 Environmental Factors and High Risk of Esophageal Cancer Among Men in Coastal South Carolina
- 2063629333-9338 Smoking and Drinking in Relation to Oral and Pharyngeal Cancer
- 2063629340-9345 Black Tobacco, Wine and Mate in Oropharyngeal Cancer. A Case-Control Study From Uruguay
- 2063629347-9352 Role of Tobacco and Alcoholic Beverages in the Etiology of Cancer Oral Cavity / Oropharynx in Torino, Italy
- 2063629354-9362 Risk Factors for Oral Cancer in Brazil: A Case-Control Study
- 2063629364-9369 Tobacco, Alcohol, Asbestos and Nickel in the Etiology of Cancer of the Larynx: A Case Control Study
- 2063629371-9380 the Epidemiological Risk Factors of the Larynx Cancer Among the Native and Migrant Male Population
- 2063629384-9393 Wspoloddzialywanie Dymu Tytoniowego I Przemyslowych Aeropolutantow (Pyly, Gazy, Opary) W Mikrosrodowiskach Pracy A Ryzyko Raka Krtani U Mezczyzn
- 2063629395-9405 Larynx Cancer Risk Factors
- 2063629407-9415 Cancer of the Larynx / Hypopharynx, Tobacco and Alcohol: Larc International Case - Control Study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva ( Switzerland) and Calvados (France)
- 2063629417-9422 Effect of Smoking and Alcohol Consumption on Laryngeal Cancer Risk in Coastal Texas
- 2063629424-9428 the Copenhagen Case - Control Study of Renal Pelvis and Ureter Cancer: Role of Smoking and Occupational Exposures
- 2063629430-9434 the Filter Cigarette and Coronary Heart Disease: the Framingham Study
- 2063629436-9442 Cigarette Smoking and Coronary Heart Disease in Puerto Rico
- 2063629446-9453 Epidemiology of Coronary Heart Disease: the Framingham Study
- 2063629455-9463 Latest Perspective on Cigarette Smoking and Cardiovascular Disease: the Framingham Study
- 2063629465-9469 'low Yield' Cigarettes and the Risk of Nonfatal Myocardial Infarction in Women
- 2063629471-9472 Tetraploid Fibroblasts and Familial Polyposis Coli
- 2063629474-9478 A Comparison of Hospitalized Veterans' Attitudes Toward Smoking and Smoking Cessation Over A Four Year Period
- 2063629482-9488 Effect of Cigarette Tar Content and Smoking Habits on Respiratory Symptoms in Woman
- 2063629490-9493 American Review of Respiratory Disease the Relationship of Tar Content to Decline in Pulmonary Function in Cigarette Smokers
- 2063629495-9510 Smoking and the Lung
- 2063629512-9518 Respiratory Effects in Relation to Estimated Tar Exposure From Current and Cumulative Cigarette Consumption
- 2063629522-9524 Increased Risk of Respiratory Symptoms in Young Smokers of Low Tar Cigarettes
- 2063629525 Childhood Respiratory Trouble (Crt) in A General Population As A Risk Factor for Airway Obstructive Diseases (Acd) in Adulthood.
- 2063629528-9541 Tobacco: A Major International Health Hazard
- 2063629543-9549 Phlegm Production and Lung Function Among Cigarette Smokers Changing Tar Groups During the 700000s
- 2063629551-9558 Correlates of Fev and Prevalence of Pulmonary Conditions in Japanese - American Men
- 2063629560-9565 Respiratory Symptoms and Low Tar Cigarette Smoking - A Longitudinal Study on Young People
- 2063629567-9572 Determinants of Chronic Mucus Hypersecretion in A General Population with Special Reference to the Type of Tobacco Smoked
- 2063629574-9586 Respiratory Symptoms, Lung Function, and Mortality in A Screening Center Cohort
- 2063629588-9597 Nicotine Exposure and Parkinson Disease
- 2063629599-9607 An Exploratory Case - Control Study of Brain Tumors in Adults
- 2063629609-9613 Cigarette Smoking and Invasive Cervical Cancer
- 2063629615-9621 Invasive Cervical Cancer and Smoking in Latin America
- 2063629623-9627 Peptic Ulcer Disease and the Tar and Nicotine Yield of Currently Smoked Cigarettes
- 2063629640-9645 Bladder Cancer and Black Tobacco Cigarette Smoking Some Results From A French Case-Control Study
- 2063629647-9650 Urothelial Cancer and Cigarette Smoking: Findings From A Regional Case-Controlled Study
- 2063629652-9661 Research Papers Smoking Habits and Risk of Cancers Other Than Lung Cancer: 28 Years' 28 Years' Follow-Up of 26,000 Norwegian Men and Women
- 2063629663-9668 Mate Drinking, Alcohol, Tobacco, Diet, and Esophageal Cancer in Uruguay
- 2063629670-9677 Adenocarcinoma of the Esophagus and Esophagogastric Junction in White Men in the United-States: Alcohol, Tobacco, and Socioeconomic Factors
- 2063629683-9690 Tobacco, Alcohol, and Socioeconomic Status and Adenocarcinomas of the Esophagus and Gastric Cardia
- 2063629692-9697 Type of Cigarettes and Cancers of the Upper Digestive and Respiratory Tract
- 2063629699-9705 Risk Factors for Cancer of the Tongue and the Mouth A Case-Control Study From Northern Italy
- 2063629707-9713 Tobacco Smoking, Alcohol Drinking, and Cancer of the Oral Cavity and Oropharynx Among U.S. Veterans
- 2063629715-9722 the Role of Tobacco, Alcohol Use, and Body Mass Index in Oral and Pharyngeal Cancer
- 2063629724-9732 Role of Alcohol and Tobacco in the Aetiology of Head and Neck Cancer: A Case-Control Study in the Doubs Region of France
- 2063629734-9740 Nasopharyngeal Cancer in A Low-Risk Population: Defining Risk Factors by Histological Type
- 2063629742-9747 Gender Differences in Smoking and Risk for Oral Cancer
- 2063629749-9752 Short Report Lung Cancer Risk Is Proportional to Cigarette Tar Yield: Evidence From A Prospective Study
- 2063629754-9757 A Case-Control Study of the Etiology of Laryngeal Cancer in Liaoning Province
- 2063629759-9763 Epidemiology of Laryngeal Cancer: Results of the Heidelberg Case-Control Study
- Date Loaded
- 07 Jun 1999
Document Images
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health
All rights reserved
Vol. 134, No. 8
Printed in U.S.A.
Tobacco Smoke Inhalation Pattern, Tobacco Type, and
Bladder Cancer in Spain. - ~,. .
..~. :.. . ~i ,:i. . " ' ~( :-. :.;. ,: ~ ,?,..... !.: : . .... " .... ., :;..,- ,:' =...
,. . .. . ., -.:... :. .::.- ...., ~..
Gonzalo L6pe.z-Abente,1 Carlos A. Gonzhlez,2 Manuel Errezola,3 Antonio Escolar,"
isabel Izarzugaza,3 Manuel Nebot,s and. E.lio Rib.oil6
bk
pa
I
.. le.~
~ po
., Th~ aSSOciati.on b~.tween tobacc.o .sine;king and bladde.r cancer was investigated in a
r:nu'l~i(~efiter (~d~e-(~6n~oi, ~tiJ~iy cbndu(~ted in five tbfovJnci~ ~fSl6aln bL=tween: 1983 an.d:
. " . "
1986. A match.ed analysis was carried out in males, based on 430 ,histologically
confirmed cases, 405 hospital controls, and 386 population controls, matched by age
and place of residence. An increased risk was found for smokers as compared with
nonsmokers (odds ratio (OR) = 3.79, 95% colafidence interval (CI) 2.41-5.97), and this
increase was significantly associated with the intensity of smoking. Smokers of filtei'-
tipped cigarettes had a reduced risk as compared with smokers of non-filter-tipped
cigarettes (OR = 0.57, 95% CI 0.32-1.02). A diminution of dsk was also observed for
smokers of low-tar and low-nicotine ("light") cigarettes. Depth of inhalation was strongly
associated with illness. No difference was shown in the logistic regression model
between smokers of black tobacco and smokers of blond tobacco after controlling for
depth of inhalation. Although the number of persons who smoked blond tobacco
exclusively was small, the results suggest that it is important to consider inhalation
patterns when studying dsk variations between smokers of black tobacco and smokers
of blond tobacco. The age at which a person started to smoke did not appear to affect
risk. An analysis of the decrease in risk associated with years since quitting smoking
suggested that different components of cigarette smoke may play a role at different
stages of the carcinogenic process. Am J Epidemio11991 ;134:830-9.
bladder neoplasms; epidemiologic methods; retrospective studie.s; smoking; tobacco
The association of cancer of the bladder
with tobacco smoking has been demon-
strated in numerous studies (1-4). However,
them are several aspects 6f smoking wh6se
role has not been fully clarified. Questions
about the finding of higher risk associated
Received for publication June 12, 1989, and in final
form March 29, 1991.
Abbreviations: CI, confidence interval; OR, odd~ ~atio;.
SD, standard deviaf on
1 Cabc.er Ei3id~miology.Onit, Nati6.na] Center.for ~p.ide-
h~iology; .Carlos III l~tl~'tJte o~'Heal~h: Madri~J, Sp~n'. ": ' ":
~ Epidemiology Unit, Hospital Sant Jaume i Santa Mag-
rJalena, Matar5, S~ain.
~ Department of Health and Social Security, Basqt~e
Government, Vitoria, Spain.
4 Primary Care Department, Andalucian Health Service,
C~.diz, Spain.
s Municipal Health Institute, Barcelona Town Halt, Bar-
celona; Spain.
~ Afialytical Epidemiol(~gy Unit,'lnternational .Acjency for
Research on Can6er, Lyon, France.
I~epdnt requests .to Dr. Gonzak~ L6pez-Abente, Servicio
of Fondo de Investigaci6n Sanitaria (FIS) grant 84/745 and
International Agency for Research on Cancer collaborative
: research agreement DEB/85/19.
.The authors .thank B. Terraccini, F. Berr.ino, and. R.
.S~acci for'their hdvice on the..d~isign of the study. They
: ~ls.b t'har~l~/~i. Ai~ud~" ar~d'~. Palazl.e'.'.for.:th.eir..Hdp-with
" "prepEation of.the data, V..Abraira, F. Pdzo, and M. Posada
for their help and suggestions in interpretation and discus-,
sion of the results, and E. Kilbourhe', M. Diez, and I. Villarino
for their assistance with the wording of the manuscript.
The following oncologists, urologists, and pathologists
and institutions, by their collaboration, made this study
possible: L Cirera,'M. Gay, and V. Marco (Mutua Terrassa
Hospital, Terrassa); J. Fabregat and A. Guzmgua (La Es-
p.eranza Hsspital, Barcelona); J." Planas. a.nd A. Gelabert
(Hospital .del Mar, Ba~celot~a); A. Badia and J. Castell~.
' be
st~
'i: .... P(
a[
of
° hi
ff
ir
tt
ir
h
~Matar6
HdSlSit~il, Matar6); J. Flor.es and R. Roldan (C&d!z
de Epid.emiolosia' del C~,ncer, Centro Nacio.n.al d.e Epi.de: . .Hospital,
C.~tdiz); J. Camacho and J. Matz (Jere;; Hospital,
miologia,'Sinesio'Oelgadp, 6, 28029 M~drid, Spain:" . Cb, diz); E.
~:ahoz and ,h,. Ruiz (L~ U0~a Hos..pital,"C&di.z};"
This .6tudy was" partly ca~rrie.d out:with the finanCial help J. k, lateos"
0.nd. A. EsCud'ero (Ramon and G..a~al H~)spitaJ,
'" - . "830 . "2 " " ": - :

Inhalation, Tobacco Type, and Bladder Cancer 831
with use of black tobacco as compared with
blond tobacco (5, 6)', the effect of inhalation
patterns (7), and other mechanisms of self-
regulation controlling blood tar and nicotine
cases who could not be interviewed, 103 had
died, 39 could not be traced, 32 refused to
answer, and 20 could not be included for
other reasons.
levels (8, .9) have not been completely, re-". : The mean length of time between ~e date
.. solved..Moreover,, the re!a.tion betw.een.t,e.m- . of .diagnosis and the interview of the patient
IJoral a~p~c~s of sm'okingin eases oF bladder - " was 22"mbnths (siand~/td deviation (SD)6:0)
cancer and the phase of the carcinogehic., in prevalent cases and 7 months (SD 3.9)
process Upon which smoking acts has not
been definitely established (5, 10). Recent
studies on the effects of ~arcinogenic com-
ponents of smok..~.on, biologic markers (11)
and Ofi i~utagenicity of the urine of~ ,rookerY"
of different types of.tobacco (12) seem to
suggest that smokers of black tobacco are at
higher risk of developing bladder cancer
than are smokers of blond tobacco.
In this analysis, we used data obtained
from a multicenter study of bladder cancer
in Spain to estimate the risk of this type of
tumor in relation to various aspects of smok-
ing.
MATERIALS AND METHODS
The cases were selected from 12 general
hospitals spread throughout five Sp~inish
provinces (Barcelona, Madrid, C~idiz, Gui-
pflzcoa, and Vizcaya). Cases were all male
and female patients with histologically con-
firmed carcinoma, polyps, or papilloma of
the bladder who were less than 80 years of
age on the date of diagnosis and were resid:
ing in the province where the hospital was
located. All new cases diagnosed between
January 1985 and March 1986 (incident
cases) and all cases diagnosed between 1983
and 1984 (prevalent cases) were included.
Of the 691 pers0ps with bladder cancer di-
agnosed ~nd identified in the .hospital regis-
ters, 497 wer.e inteffie.wed.(438, males and
59 re.males):. ~mmig.thos'e:i.nt.e .ryiewe.d, 254
(51 perc.e.nt) were iiacident eases, while 243
(49 ~ercent) were prevalent cas~s. Of the 194
Madrid); F. Arocena. R. Telleria, and R. Larburu (Nuestra
Se~3ra de Aranzazu Hosp.ital, GuipQzcoa); J. Aurteneche
and I. Hemaez (Gu~p~zcoa Hospital, Guip(JzcSa); M.
Michelena (The Oncologtcal Institute of GuipQzcoa,
GuipQzcoa); A. Perez (Cruces Hospital, Bitb.ao); J. Rores
(Bilbao Civil Hospital, Bilbao); X. Elexpe (Department Of
Health and Consumer Affairs, Basque Governr0ent,
Vitoria); and the Basque Institute of Statistic~ (Vitoria).
incident cases:
Two controls matched by sex and age
(+5 years) were included for each case. One
control.was selected .from the admission reg-
" istrr.ofthe .same hospital as.the.ease:. This .
hospital control was selected from patients
admitted on the same day or at a later date
than the case, and was someone whose dis-
charge diagnosis excluded diseases whose
risk factors were possibly related to those
under study. Patients with the following di-
agnoses :were excluded: hematuria, cystitis,
urinary lithiasis, diabetes, coronary or cir-
culatory illness, digestive or chronic pul-
monary illness, and cancer of the respiratory
system or upper gastrointestinal system (the
oropharynx, esophagus, larynx, and lungs).
Of the 827 hospital controls selected, 583
were interviewed. Of 244 who were not in-
terviewed, 116 could not be located, 66 had
died, 43 refused to answer, and 19 were lost
to follow-up for other reasons.
The second control was selected at ran-
dom from the same section of.the electoral
census or municipal register as that of the
case. Municipal registers in Spain are contin-
ually brought up to date, and the electoral
census.is updated every 4 years. Of the 807
population controls selected, 530 were inter-
viewed. Of those not interviewed, 142 could
not be located, 60 refused to answer, 55 had
died, and 20 were lost to follow-up for other
.f.eas.on...s. The .ho.spit.al controls i..ncluded 62
wrmen; and ..~he'-p6ptllati+n" controls iia-
eluded 65. :
The interviews were carried out in the
subjects' homes by trained interviewers who
were not informed as to the disease and
pathology status of those interviewed. The
questionnaire contained sections relating to
occupational history, tobacco use, passive
exposure to tobacco smoke, diet, eonsump-
tion 0.f. coffee, use of artificial gweeteners,

8,32 L6pez-Abente et al.
use of analgesics, and past history of diabe-
tes, lithiasis, and urinary infections. In the
section dealing with tobacco, a complete
history was obtained regarding the use of
cigarettes, .ici~ars, and pipe tobacco. The in-
.t~rciewrr. recorded the:amount, smoked, t.h.e..
ustiai brah~l, the .type afld cli/~r/t.cter~itics Of "
the tobacco (black, blond; filtered, hnd/or
low-tar and low-nicotine), and the duration
of. every period of smoking. Subjects were
also asked Whether or not they inhaled the
...... smoke and, if s.o, hq.w deeply: .
"':" A randb'm 10 pe}cdht ~ample of all-ques-
tionnaires was recoded, by an associate re-
searcher who was blind to case-control status
in order to assess the level of missing infor-
mation and errors in information transcrip-
tion. No substantial disagreements were ob-
served with respect to the original coding,
and there were no statistical differences be-
tween cases and controls with respect to
frequency of.errors for smoking data.
No statistically significant differences
were observed among bladder cancer cases,
hospital controls, and population controls
with respect to socioeconomic status, edu-
cational level, number of different jobs held
during the person's professional career, and
the length of the interview.
Smokers were defined as persons who had
smoked at least one cigarette per day and/
or one cigar ~ind/or two pipes per week for
at least 6 months. Ex-smokers were defined
as persons who had ceased to smoke at least
5 years before the date of diagnosis for blad-
der cancer cases and 5 years before the date
of the interview for controls.
In all analyses, jobs found to be high-risk
in our data (textile workers, mechanics,
adjusted by age and place of residence The
effect estimate was made by conditional lo-
gistic regression (14, 15) using a standard
program of epidemiglogic analysis (16). For
continuous, variables categorized in the
a..nalysis,, tests..for trend.were calculated as-
sjgnfng/m iflcre'~/sing ifiteger .to each care-
' gbry using ~ regression mrdel.'Mhtchin~ w~as
maintained throughout all phases of amil.y~
sis. Analysis was carried out on 430 sets of
males (430 cases and 791 controls--405 hos-
pital controls and 386 pbpulation controls);
.224 questior~a.ires .were-.exclu.ded..bec.a.use
the set did not contain at least one 6ase~and
one control, and 165 questionnaires from
women were excluded because of the scar-
city of women smokers (four cases and two
controls).
In the results presented in tables 2 and 5,
we excluded persons who smoked only ci-
gars or pipes.
The two control groups have been ana-
lyzed together, because no difference was
found between them with regard to the pro-
portions of current smokers, ex-smokers,
and nonsmokers (table 1) and because the
odds ratios were similar for the average num-
ber of cigarettes smoked per day when the
two groups were analyzed separately.
RESULTS
The mean ages of cases, hospital controls,
and population controls were 62.4 (SD
11.2), 63.6 (SD 11.0), and 63.1 (SD 11.3)
years, respectively.
Table 2 shows the relations between the
various levels of cigarette smoking and the
risk of bladder cancer in males. Age and
place of r~sidence were controlled by match-
graphic artists, and directors) (13) wer~
t~.st.ed as: pote.ntially cq.nfouu. i.din.g v.arj.'ab.le£...... Lug. For certain associations
(cigarettes)day,
A tiistoi3r 'of tiriha~y infections v~as '~sb:" ci~atett~s~iifefl~e, ::~ars 6'f smo~ig,-.and.'.
tested as a p.oteritial confofinder. In some of years since" quitting s.moking), .there was a"
the analyses presented here (tables 3, 4, 6,
and 7), the comparisons were made within
the group of smokers because of the need to
adjust for other variables of exposure to
tobacco. ..
A matched analysis was carried out to
estimate the odds ratio for each variable. For
that reason, th~ risk ~sfimates presented are.
:
statistically significant dose response; and
the odds ratios in heavy smokers were over
4.
With regard to the average number of
cigarettes smoked per day, it appears that
the relation reaches a plateau above 20 cig-
arettes per day. Ho.wever, when one exam-
"tries. the. .to.tal nu.rn.b,ers o,f .cigarettes smoked
TAB/
1983
less
syn
sm
sm
l
sin
exl
od
16
in
Or
re
te
W
1"
r(
a
t:
' t)
C
(
(

Inhalation, Tobacco Type, and Bladder Cancer 83:3
TABLE 1. Distribution of hospital .and population controls according to their smoking habits, Spain,
1983-1986
Current
smokers (cigarettes/day) Cigar
Nonsmokers Ex-smokers
1-10
11-20 21-30" >_31 smokers
Hospital controls*
(n=405) " . . 73.
"" ' "."..- (1.8.2)1"
- 15opulatior~ c0ntrols~
(n = 386) 75
(19.6)
89 48 130 38 " " 14 9 .
(22.2) "'.. (12.0) ...(3.2:.4).i'' (9.5)...(3:5).. (2.2,) .... "
107 45 96 40 .. 12 8
(27.9)~ (11.7) (25.!) (10.4) (3.1) "(2.1) -
* Data were missing fo( four hospital controls and three population controls.
1 Numbers in parentheses, i~ercentage.
"over aiifet[m~i 'tl~e piateau eff~dt l~e~rmes:
less evident, probably because this variabl.e
synthesizes the information on years of
smoking mid average number of cigarettes
smoked daily.
Risk of bladder cancer decreases with time
since stoi~ping smoking, but not to the same
extent as in the case of lung cancer (17); the
odds ratio for those who gave up smoking
16 or more years prior to interview was 2.37.
Risk was similar among incident cases and
prevalent cases. We evaluated this in logistic
regression models, including an interaction
term between the analyzed determinant and
an incident or prevalent set indicator.
The odds ratio (adjusted for age and prov-
ince of residence) for cigar smokers, using
only individuals who never smoked ciga-
rettes, was 1.32 (95 percent confidence in-
terval (CI) 0.41-4.27). Twenty-one persons
who smoked cigars exclusivel~r (4 cases and
17 controls) were included in this analysis.
Table 3 shows our results for the effects
of filter-tipped, non-filter-tipped, and hand-
rolled cigarettes. The categories presented
are those for smokers of exclusively these
types of cigarettes, with the exception of the
."mixed" category, which comprise.s variou~
. "types.of-t.obaccO u.s6. This c.ategory ir~cluded
the greatest proportionof ~mokers. an.d; for
this reason, .we used it as the refe~:ent when
calculating the odds ratios.
The results suggest that the filters give a
certain amount of protection, independently
of the other indicators of exposure. Risk
estimates did not vary when. we took into
account the number of years of smoking and
the date (year) of beginning smoking. The
i~rrtlofi. 0f d~ep ihhalers in- ~he
group was greater among smokers of filter-
tipped cigarettes (59.7 percent) than among
smokers of non-filter-tipped cigarettes (28.0
percent). Among smokers of hand-rolled cig-
arettes, 41.1 percent inhaled deeply.
In the initial analysis including only type
of tobacco (unadjusted for number of ciga-
rettes or inhalation, and using nonsmokers
as the reference group), there was a slightly
greater risk for smokers of black tobacco
(odds ratio (OR) = 3.71, 95 percent CI 2.39-
5.78) than for smokers of blond tobacco
(OR = 3.16, 95 percent CI 1.52-6.58).
Table 4 shows results for type of tobacco
(black vs. blond) after adjustment for num-
ber of cigarettes smoked per day, depth of
inhalation, and years of smoking, using
smokers of black tobacco as the reference
group. We found no difference in this analy-
sis between the two types of tobacco. The
categories included those who smoked one
or the other of the two types of tobacco
exclusively The confounding effect of the~
variable "depth of inhalation" was higher
than that of the covariate "number of ciga-
rettes smoked per day." The proportion of
inha.l~rs was greater amon~ users of black
tob.ac.c9 tho/a, among users of, .blond t0ba.c~b, ";
- for brth dase.s and controls (90" perdent vs.
84 percent in "cases and 79 percent vs. 65 "
percent in controls).
We do not know what level of precision
was achieved in the gathering of information
on inhalation. We assumed, in this analysis,
that the smoker knew this aspect of his
smoking well, although the depth of his in-
halation may have v.aried over his lifetime.

834 L6pez-Abente et al.
TABLE 2. Odds ratios for bladder cancer in males according to degree of cigarette smoking (as
compared
with nonsmokers), Spain, 1983-1986
Variabte and categon/ , No. of No. of
OR*.'{" 95%
. . cases controls
.' Smoking
:. .: .'-, .:Nonsmoker
.. : EYer'~/noker "
Nonsmoker "
Ex-smoker.
Curre, nt s~oker
27
~7
.90
309
148 1.00
196 2.69
426 4.37
Ever smoking(average no.
ofcigare~es/day)
0 27 ,
1-10 59,
11-20 "':" '" ": " " "": .245 :~'. " ."
21-30 66
>30 26
148
174 "
305 " .'...
102 " ""
37
(Referent)..
2.4i -5.97
"(Referent) :
1.61 -.4.49.
2.75-:,6.95
1.00 (Referent)
1.88 1.10-3.20
.4.84.. , . 3;01-7.78
4.10 2.3~-~.13
4.21 2.11-8.43
X2 trend~: = 40.0 p < 0.0001
Current smoking (average
no. of cigarettes/day)
0 27 148 1.00
(Referent)
1-10 39 93 2.40
1.35-4.28
11-20 201 226 5.28
3.25-8.57
21-30 48 78 3,92
2.17-7.07
>30 19 26 4.34
2.04-9.24
x~ trend.l: = 31.5 p < 0.0001
Years of smoking
0 27 148 1.00
(ReferenO
1-19 " 23 66 1.80
0.94-3.45
20-39 137 221 3.91
2.35-6.49
40-59 222 311 4.66
2.87-7.54
->60 17 24 4.44
2.02-9.78
x=trend~ = 41.5 p < 0.0001
Years since quitting smoking
Nonsmoker 27 148 1.00
(Referent)
->-16 38 91 2.37
1.32--4.26
6-15 52 105 2.99
1.71-5.22
0-5 309 426 4,38
2.75-6.97
X2 trend~c = 44.0 p < 0.0001
Ufetime smoking (no. of
cigarettes/lifetime)
0 27 148 1.00
(Referent)
<150,000 73 195 2.21
1.33-3,68
150,000-299,999 .. 183 242 4.56
2.82-7.37
->300,.000.... 140 181 ,4.88
2.94-8.08
.::. ",-~ . ,'." ;-.
~:i;.~.~'tr.end:l:.~'~,9.9,.
-~ _ p < 0.0001
Mi
". :N~
. Fil
i
smc
sine
~. . ~ . ana
1
* OR. odds ratio; CI, confidence ~nterv~L " "
1" Adjusted for age and place of residence (matched conditional Iogis{ic regression analysis).
Odds ratioswere "dedved from the
matched analysis and cannot be calculated directly from the unmatched distribution of cases and
control~ shown in the table.
~ Trend test for dose response.
However, the results in table 5 appear to be
particularly cons!stent, since one may ob-
serve a clear variation of effect based on
depth of inhalation.- ..
The inhalation covariate, in theoretic
terms~ is a modifier of the effect of other
aspects of smoking, That is, the effect asso-
ciated with the number of cigarettes smoked .

Inhalation, Tobacco Type, and Bladder Cancer 835
TABLE 3. Odds ratios for bladder i:ancer in male
cigarette smokers a,ccording to use of filter-tipped
cigarettes, Spain, 1983-1986
Type of cigarette No. of No. of OR*, i 95% CI*
cases controls
Mixed use 330 469 .1..00 (Referent)
.. " Hand-.rolled 30 " 58 " 0.9"4 .0.54z1.66
Filter-tipped .26 69 0.57 .0.32-1.02
* OR, odds ratio; CI, confidence interval.
1 Adjusted for age, place of residence, no. Of cigarettes
smoked per day, depth of inhalation, cigar smoking, and years
since quitting smoking (matched conditional logistic regression
analysis).
per day varies betWeen inhalers and nonin-.
balers. In our analyses, there was a signifi-
cant interaction between number of ciga-
rettes smoked per day and depth of inhala-
tion. The. result of the likelihood ratio test
for the model with and without an interac-
tion term was x2 (6 df) = 14.90 (p = 0.02).
In table 6, we present the estimates of risk
for both, taking into account the interaction
term. Among persons who inhaled deeply,
number of cigarettes smoked per day was a
less important determinant of bladder can-
cer risk.
Low-tar and low-nicotine ("light") ciga-
rettes have only recently been put on the
market in Spain. The number of smokers
who smoked this type of tobacco exclusively
was very small (nine cases and one control).
In table 7, we grouped together thos~ who
smoked exclusively light tobacco and those
who smoked both light and regular tobacco
and compared them with those who smoked
only regular tobacco. A diminution of risk
was observed from the smoking of some light
tobacco.
The tar and nicotine content of t~)bacc0
has gone down in recent, decades (18). We.
could -riot .detect differences.in-., odds ratios
by yea~: of starting to smoke. For those Siab-
jects who started smoking in 1955 or earlier
(using as the reference group subjects who
started after 1955), the odds ratio was 1.07
(95 percent CI 0.50-2.30). The estimate was
adjusted for age; place of residence, number
of cigarettes smokedper day, depth of in-
.halation, and years since quitting smoking.
The age at which a person started to smoke
did not appear to affect the risk.
Having a high-risk job was not a con-
founding variable in any of the analyses.
The odds ratio for a person who smoked
more than 30 cigarettes per day and worked
in a high-risk job was 9.6. The odds ratio for
having a high-risk job was 2.03 (95 percent
CI 1.49-2.77) (13). Assuming the suitability
of the logistic regression model in this analy-
sis, these data suggest the existence of a
multiplicative effect for the two exposures.
in figure 1, we show odds ratios for ex-
smokers by time since cessation of smoking
(using current smokers as the reference cat-
egory) and by the presence or absence of
occupational exposure. The figure shows a
rapid decrease in risk in the years that follow
quitting smoking but later on a slight in-
crease and stabilization. In persons with
TABLE 4. Odds ratios for bladder cancer in male cigarette smokers according to type of tobacco
smoked,
Spain, 1983-1986
Black tobacco] Blond tobacco
Mixed tobacco
Potential confounders (n = 286/461):1: (n = 19/34)
. (n = 93/128)
considered* ....
' OR§. -OR " 95?/o el§
" .. OR "95% Cl '.
None 1.00 0.99 0.522i.88 " ~.08
0.78-1.50
No. of cigarettes/day 1.00 1.1 4 0.59-2.18 1.05 0.76-1.47
Depth of inhalation 1.00 1.25 0.65-2.43 1.07 0.76-1.50
No. of cigarettes/day,
depth of inhalation,
and years of smoking 1.00 1.40 0.71-2.75 0.99
0.70-1.39
* Variables adjusted for in addition to matched variables (conditional logistic regression
analysis).
1 Referent.
:1: No. of cases/no, of controls.
§ OR, odds ratio; CI, confidence interval.

836 L6pez-Abente et al.
TABLE 5. Odds ratios for bladder cancer in male
cigarette smoke~s according to depth of inhalation,
Spain, 1983-1986
No. of No. of
cases ~ntrols OR*, 1 95% CI*
Nbnsmoker. " 27 14~ .1.00; (Referent)
No inhalation 35 124". 1.5.0" 0.84~-2.69 '
Depth of inhalation
Moderate 87 143 3.67 2.16-6.24
Deep 272 352 4.86 3.02-7.82
* OR, odds ratio; CI; confidence interval.
1" Adjusted for ag.e and p!ace of residence (matched condi-
tional logistic regression analy.sis).
TABLE 6. Odds ratios* for bladder cancer in m.ale
cigarette smokers according to number of
cigarettes smoked per day and depth of inhalation,
Spain, 1983-1986
No. of No Moderate Deep
cigarettes/day inhalation inhalation inhalation
1-10 1.001" 2.05 1.91
11-20 1.62 3.89 4.59
21-30 2.62 3.18 3.92
>30 4.24 3.56 3.84
* Adjusted for age, place of residence, and use of filter-
tipped cigarettes (matched conditional logistic regression analy-
sis).
1" Referent.
TABLE 7. Odds ratios for bladder cancer in male
cigarette smokers according to use of low-tar and
low-nicotine ("light") cigarettes, Spain, 1983-1986
No. of No. of OR*, 1" 95%
cases controls
Regular ciga-
rettes 380 572 1.00 (Referent)
Both light and
regular ciga-
rettes 16 48 0.49 0.25-0.96
* OR, odds ratio; CI, confidence interval
1" Adjusted for age, place or residence, use of filter-tipped
cigarettes, no. of cigarettes smoked per day, and inhalation
(matched conditional logistic regressi .on analysis).
~gh-~isk j6b~ (oCC~l~atibnalls; exposed), the'"
pattern of the curve is different.
The population attributable risk (19) as- '
sociated with cigarette smoking was 67 per-
cent.
DISCUSSION
The adjusted mortality rate for bladder
cancer among men in Spain increased 60
percent between 1955 and 1975 (20). In
)DD8 RATIO
1.6"
1.4 ..... =~’_ ~ -~- NOT OGGUPAT. EXP.
0.8"
"1
0 10 20 80 40 50
YEARS SINCE QurVrlNG SMOKING .
" F~uB'E'I. 06d~ ratios~for'bladder'eit~cer ln'~naie-e-~- : " "
smokers versus male current smokers, by years since
quitting smoking and by occupational exposure, Spain,
.1983-.1986. Estimates were adlusted for liletime num-
ber of cigarettes smoked. Age and place of residence
were controlled by matching.
1985, the adjusted mortality rate (world
standard population) in women was 1.10 per
100,000 person-years, as compared with
7.81 per 100,000 person-years in men (un-
published data). Smoking was extremely
rare among the women in this study; their
average age was 68 years.
Tobacco smoke contains a large number
of carcinogens. Two of them are 2-
naphthylamine and 4-aminobiphenyl, both
known to cause bladder cancer (11, 21).
The relation between dose and response
shown in table 2, based on the average num-
ber of cigarettes smoked per day, shows a
leveling off and even a negative slope for
smokers of more than 20 cigarettes per day.
This leveling of the odds ratios has been
described by others (4, 5, 22, 23). A number
of different explanations have been sug-
gested, including an underestimation of to-
bacco use among heavy' z.mokers (22), .the
~i~tence of diseases.reJ.atedtd-s'mqldng that
appear .~arlier than" bIa.dde'r cancer (4);" ~nd
imperfect comparability between dases and
controls because of design problems (5). This
leveling off lessens when another variable
such as total or lifetime smoking is analyzed.
However, this stabilization of risk has not
been observed for other tumors of the uro-
logic system such as those of the renal pelvis
and ureter (24). The stabilization of the
mutagenic effect of urine observed by
Malaveille et al. (12) ir
20 or more cigarettes I
ing.
Recent studies ha)e
. of a ~reater risk associ
)~obac~o cigarettes, ~
twice the risk as d6 blt
(5, 6, 25), arid it has b
greater concentration
s~cific to bladder c~
black tobacco .might e
.otrr.s.t.udy~ howeyer, t}
seen. The relative risk
Italy was higher than
United States and En~
that could be due to
black tobacco smoki
countries. The habit
bacco exclusively was
uiation we studied.
Other hypotheses w.
difference in findings !
others are errors in th,
of tobacco and an ac:
inhalation as a risk fa
etiology.
As for the methoc
interviewed with rega
used (black or blond),
a list of all the type
Spain. The interview,
instructions on how
taught to consult it. Ifa
error, it would have be
would have masked ~
blond and black toba~
In the logistic regre
we evaluated the diffe
blond and black tobac
seemed to be a ne~ati'
S'..moki~g- p .atterns ..di
who smbked exclusiv
those who smoked
bacco. Smokers of t
more (and smoked ~r
vs. 12.4 cigarettes/da:
than smokers of Non,
~Depth of inhalafio
in the estimation of
. other case-control stu
ated with depth of int

Inhalation, Tobacco Type, and Bladder Cancer 837
Malaveille et al. (12) in persons who smoked
20 or more cigarettes per day is rather strik-
ing.
Recent studies have revealed the existence
of a greater risk associated with Use of black
tobacco cigarettes, whidh present a]most
twice the risk as do blond tobacco cigarettes
(5, 6, 25), and it has been suggested that the
greater concentration of aromatic amines
specific to bladder cancer in the air-cured
black tobacco might explain this finding. In
our ~tudy, howe'~er, this difference wa~ not.
seen. The relative risk observed in Spain and
Italy was higher than that observed in the
United States and England (4, 26), a finding
that could be due to the predominance of
black tobacco smoking in Mediterranean
countries. The habit of smoking blond to-
bacco exclusively was infrequent in the pop-
ulation we studied.
Other hypotheses which might explain the
difference in findings between our study and
others are errors in the classification of type
of tobacco and an actual effect of depth of
inhalation as a risk factor in bladder cancer
etiology.
As for the method of classifying those
interviewed with regard to type of tobacco
used (black or blond), coding was done from
a list of all the types of tobacco used in
Spain. The interviewers had this list, .with
instructions on how to use it, and were
taught to consult it. If there was classification
error, it would have been nondifferential and
would have masked the difference between
blond and black tobacco (27).
In the logistic regression model in which
we evaluated the differences in risk between
blond and black tobacco, depth of inhalation
see.med .to .be a negative ct)nfounding factor.
Smoking 15atterns differed between those
who smoked exclusively black tobacco and
those who smoked exclusively blond to-
bacco. Smokers of black tobacco inhaled
more (and smoked more: 16 cigarettes/day
vs. 12.4 cigarettes/day in the control group)
than smokers of blond tobacco.
Depth of inhalation was very important
in the estimation of risk in our study. In
other ease-control studies, no effects associ-
ated with depth of inhalation were noted (3,
26), although, in one of them (26), the ques-
tion was posed differently. The finding of an
effect associated with depth of inhalation is
plausible, since it is pr6sently accepted that
the intake of various components of tobacco
depends not only ori th~ /iumber of ciga-
rettes smoked biat also on the extent and
frequency of puffing and the depth of inha-
lation (8, 9, 28-30).
A change in the type of tobacco used
produces, an adjustment of smoking habits
which tends to ~lf-regulate blood tar and.
nicotine levels (8, 9). Therefore, the assess-
ment of the separate effects of blond and
black tobacco could be improved, avoiding
misclassification, by analyzing clean cate-
gories of exposure (i.e., by analyzing persons
who smoked exclusively one type of cigarette
or the other).
Malaveille et al. (12), in their study of
levels of mutagens in the urine of smokers
of black and blond tobacco, found twice as
much mutagenic effect in smokers of black
tobacco as in smokers of blond tobacco
when they adjusted for nicotine and cotinine
levels in urine. According to their results,
the condensate of black tobacco central
smoke contains more nicotine than that of
blond tobacco smoke, but per cigarette
smoked, smokers of black tobacco excrete
less nicotine in the urine; this is why their
findings on mutagenicity were confounded
by the number of cigarettes smoked. Indeed,
when calculating the mutagenic effect ac-
cording to number of cigarettes smoked per
day, Malaveille et al. could not find differ-
ences between the two types of tobacco (12).
Although persons who smoke black to-
bacco present higher levels of hemoglobin
adducts of aromatic amines than those who
smoke blond tobacco (adjusting. for the
number of cigarettes), 4-aminobiphenyl and
3-aminobiphenyl levels are equal in the cen-
tral smoke of both types of tobacco (11). We
do not know how inhalation pattern might
have affected these results.
We did not find risk variations in relation
to age at starting smoking. This is in agree-
ment with previous observations (5).
In figure 1, there is a rapid decrease in
risk in the years that folIow quitting smok-

838 L6pez-Abente et al.
ing, but in later years a slight increase and
stabilization can be observed. Ttae first part
of the curve is .compatible with a late-stage
.carcinogenic" mecha.nism and the second
with an early-stage mechanism (31). Quit-
ting smoking does not result in the risk's
returning to a nonsmoker's level, probably
because the carcinogenic biologic mecha-
nism has already been triggered. It is possible
that cigarette smoke .has some effect'on both
ph~ises of the carcinogeriic process in bladder
cancer, as happens in lung.cancer (32). In
persons who are occupationally exposed to
chemical carcinogens, the pattern of the
curve is different. Although temporary as-
pects of job exposure have not been con-
trolled for in this analysis, this pattern might
represent an effect modification phenome-
non.
The results shown confirm that the risk of
bladder cancer's developing in cigarette
smokers depends on the intensity of the
habit, the number of years of smoking, and
the amount of tobacco smoked during a
lifetime.
We think that inhalation intensity (fre-
quency and depth) should be measured at
each different point in the tobacco use
history of an individual. Since it might be
difficult to conduct these measurements,
laboratory studies should be carried out to
measure exposure by means of biologic
markers for inhalation patterns and for type
and amount of tobacco consumed.
REFERENCES
1. Lilienfeld AM,.Levin ML, Moore GE. The associ-
ation of smoking" with cancer of the urinary bladder
in humans. Arch Intern Med 1956;98:129-35.
2. Cole P, Monson RR, Haning H, et al. Smoking
and cancer of the lower urinary tract. N Engl J
Med 1971;284:129-34.
3. Howe GR, Burch JD, Miller AB, et al. Tobacco
use, occupation, coffee, various nutrients, and blad-
der cancer. J Natt Cancer Inst 1980;64:701 - 13.
4. Cartwright RA, Adib R, Appleyard I, et al. Ciga-
rette smoking and bladder cancer: an epidemiolog-
ical inquiry in West Yorkshire. J Epidemiol Com-
munity Health 1983;37:256-63.
5. Vineis P, Esteve J, Terracini B. Bladder cancer and
smoking in males~ types of cigarettes, age at start,
effect of stopping, and interaction with occupation.
Int J Cancer 1984;34:165-70.
6. Iscovich J, Castelletto R, Esteve J, et al. Tobacco
smoking, occupational exposure, and bladder can-
cer in Argentina. Int J Cancer 1987;40:734-40.
7. Wald NJ, Idle M, Boreham J, et al. Inhaling habits
among, smokers of different types of cigarette.
Thorax 1980;35:925-8.
8. Herning RI, Jones RT, Benowitz NL, et al. How a
cigarette is smoked determines blood nicotine lev-
els. Clin Pharmacol Ther 1983;33:84-90.
9. Sutton SR, Russell MAH, Iyer R, et al. Relation-
ship between cigarette yields, puffing.patterns, and
smoke intake: evidence for tar compensation? Br
MedJ 1982;285:600-3.. .,
10. Decarli A, Peto J, Piolatto G, et al. Bladder c~ncer"
moi-tality of workers exposed to aromatic amines:
analysis of models of carcinogenesis. Br J Cancer
1985;51:707-12.
11. Bryant MS, Vineis P, Skipper PL, et al. Hemoglo-
bin adducts of aromatic amines: associations with
smoking status and type of tobacco. Proc Natl Acad
Sci USA 1988;85:9788-91.
12. Malaveille C, Vineis P, EstEve J, et al. Levels of
mutagens in the urine of smokers of black and
blond tobacco correlate with their risk of bladder
cancer. Carcinogenesis 1989; 10:577-86.
13. Gonz~ez CA, L6pez-Abente G, Errezola M, et al.
Occupation and bladder cancer in Spain: a multi-
centre case-control study. Int J Epidemiol 1989;
18:569-77.
14. Breslow NE, Day NE, Halvorsen KT, et al. Esti-
mation of multiple relative risk functions in
matched case-control studies. Am J Epidemiol
1978;108:299-307.
15. Breslow NE, Day NE, eds. Statistical methods in
cancer research. Vol I. The analysis of case-control
studies. Lyon, France: International Agency for
Research on Cancer, 1980. (IARC scientific publi-
cation no. 32).
16. EPILOG. Version 3.06. Pasadena, CA: Epicenter
Software, 1986.
17. Benhamou S, Benhamou E, Tirmarche M, et al.
Lung cancer and use of cigarettes: a French case-
control study. J Natl Cancer Inst 1985;74:1169-75.
18. Klus H. Low-tar cigarettes: possibilities and limi-
tations. In: Zaridze D, Peto R, eds. Tobacco: a
major international health hazard. Lyon, France:
International Agency for Research on Cancer,
1986:265-81..(IARC scientific publication no. 74).
19. Miettinen OS. Proportion of disease caused or pre-
vented by a given exposure, trait or intervention.
Am J Epidemiol 1974;99:325-32. . ' " .
20. L6pez-Abente G: Bladfder cance/"in Spain: mortal"
ity trends (i 955-1975). Cancer 1983;51:2367-70.
2 I. Hoffmann D, Wynder EL. Chemical constituents
and bioactivity of tobacco smoke. In: Zaridze D, -
Peto R, eds. Tobacco: a major international health
hazard. Lyon, France: International Agency for
Research on Cancer, 1986:145-65. (IARC scien-
tific publication no. 74).
22. Wynder EL, Goldsmith R. The epidemiology of
bladder cancer:, a second look. Cancer I977;40:
1246-68.
23. Schifflers E, Jamart J, Renard V. Tobacco and
occupation as risk factors in bladder cancer: a caser
control study in southern Belgium. Int J Cancer
1987;39:287-92. "
24. Jensen OM, Knudsen JB, McLaughlin JK, et al.
The C,
and u~
tional.
25. Vineis
and ty
cancer
26. Hartgc
cigaret
contro
27. Copek
Bias d
relatiw
28. Peach
..... inexpe
Peto R
hazard

Inhalation, Tobacco Type, and Bladder Cancer 839
27.
The Cope~hhgen case-control study of renal pelvis
and ureter cancer: role of smoking and occupa-
tional exposures. Int J Cancer 1988;41:557-61.
25. Vineis P, Esteve J, Hartge P, et al. Effects of timing
and type of tobacco in cigarette-induced bladder
cancer. Cancer Res 1988;48:3849-52.
26. Hartge P, Silverman D, Hoover R, et al. Changing
cigarette habits and bladder cancer risk: a case-
control study. J Natl Cancer Inst 1987;78:1119-25.
Copeland KT, Checkoway H, McMichael A J, et al.
Bias due to misclassification in th6 estimation of
relative ri~k. Am J Epidemiol 1977;105:488-95.
28. Peach H, Morris RW, Ellard GA, et al. A simple,
inexpensive t/rine test of smoking. In.: Zaridze D,
Peto R, eds. Tobacco: a major int.emational health
hazard. Lyon, France: International Agency for
29.
Research on Cancer, 1986:183-93. (IARC scien-
tific publication no. 74).
Vogt TM, Selvin S, Hulley SB. Comparison of
biochemical and questionnaire estimates of tobacco
exposure. Prev Med 1979;8:23-33.
30. Slattery ML, Schumacher MC, West DW, et al.
Smoking and bladder cancer: the modifying effect
of cigarettes on other factors. Cancer 1988;61:
402-8.
31. Day NE, Brown CC. Multistage models and pri-
mary prevention of cancer. J Natl Cancer Inst
1980;64:977-89.
32. Brown CC, Chu K. Use of multistage models to
infer stage affected by carcinogenic exposu.re: ex-
ample of lung cancer and cigarette smoking. J
Chronic Dis 1987;40(suppl 2):171S-9S.
